References
- E.G. de Jalon, M.J. Blanco-Prieto, P. Ygartua and S. Santoyo, Topical application of acyclovir-load microparticles: Quantification of the drug in porcine skin layers, J. Controt. Rel., 75, 191-197 (2001) https://doi.org/10.1016/S0168-3659(01)00395-9
- E.G. de Jalon, M.J. Blanco-Pheto, P. Ygartua and S. Santoyo, Increased efficacy of acyclovir-loaded microparticles against herpes simplex virus type 1 in cell culture, Eur. J. Pharm., 56, 183-187 (2003) https://doi.org/10.1016/S0939-6411(03)00068-7
- J.H. Lee, Y.S. Kim, C.K. Lee, H.K. Lee and S.S. Han, Antiherpetic activities of natural naringenin alone and in combinations with acyclovir and vidarabine, J. Kor. Pharm. Sci., 43, 77-84 (1999)
- S.H. Park, H.H. Kim and K.P. Lee, Dissolution rate bioavailability of acyclovir, antiviral agent, by cyclodextrin inclusion complexation, J. Kor. Pharm. Sci., 28, 257-266 (1998)
- Y.E. Nashed and A.K. Mitra, Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir, Spectrochimica Acta Part A, Mol. Bio. Spectro., 59, 2033-2039 (2003) https://doi.org/10.1016/S1386-1425(03)00007-6
- C.U. Nielsen, R. Andersen, B. Brodin, S. Frokjaer and B. Steffansen, Model prodrugs for the intestinal oligopeptide transporter: model drug release in aqueous solution and in various biological media, J. Control. Rel, 73, 21-30 (2001) https://doi.org/10.1016/S0168-3659(01)00233-4
- C. McGuigan, M.J. Slater, N.R. Parry, A. Perry and S. Harris, Synthesis and antiviral activity of acyclovtr-5'-(Phenyl methoxy alaninyl) Phosphate as a possible membrane-soluble nucleotide prodrug, Bio. Med. Chem. Lett., 10, 645-647 (2000) https://doi.org/10.1016/S0960-894X(00)00061-5
- J.K. Jeong, G. Khang, J.M. Rhee, H.C. Shin and H.B. Lee, Effect of molecular weights and mixture ratios of polyvinylpyrrolidone on the bioavailability of ipriflavone solid dispersion, J. Kor. Pharm. Sci., 30, 235-239 (2000)
- H.J. Kil, S.H. Cho, G. Khang, S.Y. Jeung, K.S. Seo, B.Y. Yoon, B.K. Kang and H.B. Lee, Preparation of solid dosage form containing SMEDDS of simvastatin by microencapsulation, J. Kor. Pharm. Sci., 33, 121-127 (2003)
-
L.A. Hergert and G.M. Escandar, Spectrofluorimetric study of the
\beta -cyclodextrin-ibuprofen complex and determination of ibuprofen in phamaceutical preparation and serum, Talanta, 60, 235-246 (2003) https://doi.org/10.1016/S0039-9140(03)00095-X - M.E. Yue, T.F. Jiang and Y.P. Shi, Fast determination of flavonoids in Hippophae rhamnoides and its medicinal preparation by capillary zone electrophoresis using dimethylcyclodextrin as modifier, Talanta, 62, 695-699 (2004) https://doi.org/10.1016/j.talanta.2003.09.024
- L.M. Prince, A theory of aqueous emulsion. I. Negative interfacial tension at the oil/water interface, J. Colloid Interface Sci., 23, 165-173 (1967) https://doi.org/10.1016/0021-9797(67)90099-9
- H.S. Kim, S.K. Lee, S.U. Choi, H.S. Park, H.J. Jeon and Y.W. Choi, Improved dissolution characteristics of ibuprofen employing self-microemulsifying drug delivery system and their bioavailability in rats, J. Kor. Pharm. Sci., 32, 27-33 (2002)
- D. Attwood, C. Mallon and C.J. Taylor, Phase studies of oil-in-water phospholipod microemulsions, Int. J. Pharm., 84. R5-R8 (1992) https://doi.org/10.1016/0378-5173(92)90063-8
- M.A. Pue, S.K. Pratt, A.J. Fairless, S. Fowles, J. Laroche, P. Georgiou and W. Prince, Linear pharmacokinedcs of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 to healthy volunteers, J. Anti. Chemo., 33, 119-127 (1994) https://doi.org/10.1093/jac/33.1.119
- E.J. Benjamin, B.A, Firestone, R. Bergstrim, M. Fass, I. Massey, I. Tsina and Y.T. Lin, Selection of a derivatives of the antiviral agent 9-[(1,3-dihydroxy-2-proxy)-methy1]guanine with improved oral absoiption, Pharm. Res., 4, 120-125 (1987) https://doi.org/10.1023/A:1016462801968
- N. Coceani, I. Colombo and M. Grassi, Acyclovir permeation through rat skin: mathematical modeling and in vitro experiments: Int. J. Pharm., 254, 197-210 (2003) https://doi.org/10.1016/S0378-5173(03)00028-0
- K. Basavaiah and H.C. Prameela, Simple spectrophotometric determination of acyclovir in bulk drug and formulations: IL FARM., 57, 443-449 (2002) https://doi.org/10.1016/S0014-827X(02)01237-5
- G. Khang, J.K. Jeong, J.S. Lee, J.M. Rhee and H.B. Lee, Recent development trends of the improving bioavailability by polymeric nano vehicles of poorly water soluble drugs, Poly. Sci. Tech., 13, 342-359 (2002)
- G. Khang, J.K. Jeong, J.M. Rhee, J.S. Lee and H.B. Lee, Effect of hydrophilic polymers on solid dispersion of ipriflavone to improve bioavailability, Macro. Chem. Sym., 14, 123-132 (2001)
- J.K. Jeong, G. Khang, J.M. Rhee, H.C. Shin and H.B. Lee, Comparative bioavailability of iprifavone by pharmaceutical preparation types, J. Kor. Pharm. Sci., 30, 21-26 (2000)
- K. Sekiguch and N. Obi, Studies on absorption of eutectic mixture. A comparison of behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man, Chem. Pharm. Bull, 9, 866-872 (1961) https://doi.org/10.1248/cpb.9.866
- M. Zacchigna, G.D. Luca, V. Maurich and E. Boc, Syntheses, chemical and enzymatic stability of new poly(ethyleneglycol)-acyclovir prodrugs, IL FARM., 57, 207-214 (2002) https://doi.org/10.1016/S0014-827X(01)01193-4
- S.L. Law, K.J. Huang and C.H. Chiang, Acyclovir-containing liposomes for potential ocular delivery corneal penetradon and absorption, J. Controt Rel, 63, 135-140 (2000) https://doi.org/10.1016/S0168-3659(99)00192-3
- J.K. Jeong, J.H. Kim, G. Khang, J.M. Rhee and H.B. Lee, The preparation and characterization of solid dispersion of ipriflavone with PVP, J. Kor. Pharm. Sci., 32, 179-189 (2002)
- B. Conti, C. Bucolo, C. Giannavola, G. Puglisi, P. Ginuchedi and U. Conte, Biodegradable microspheres for the intravenous administration of acyclovir, Eur. J. Pharm. Sci., 5, 287-293 (1997) https://doi.org/10.1016/S0928-0987(97)00023-7
- H. Bando, M. Saahashi, T. Takagi, F. Yamashita, Y. Takakura and M. Hashida, Analysis of in vitro skin penetration of acyclovir prodrugs based on a diffusion model with a metabolic process, Int. J. Pharm., 135, 91-102 (1996) https://doi.org/10.1016/0378-5173(96)85199-4
- M. Demangone, J.M. Hill and B.S. Kwon, Effects of acyclovir therapy during simultaneous reactivation of latent HSV-1 in rabbits, Anti. Res., 7, 237-243 (1987) https://doi.org/10.1016/0166-3542(87)90032-5
- M. Yamazaki, S. Itoh, M. Sawanoi, M. Kobayshi, S. Suzuki, T. Komatsu and K. Tanabe, The effect of fatty acids on the rectal absorption of acyclovir in rats, J. Pharm., 42, 441-443 (1990) https://doi.org/10.1111/j.2042-7158.1990.tb06589.x
- H. Vergin, C. Kikuta, H. Mascher and R. Metz, Pharmackinetics and bioavailability of different formulations of acyclovir. Arzneim-Forsch., 45, 4 (1995)
-
E.G. de Jal
$\'o$ n, M.J. Blanco-Pr$\'i$ eto, P. Ygartua and S. Santoyo, Increased efficacy of acyclovir-loaded microparticles against herpes simplex virus type 1 in cell culture, Eur. J. Pharm., 56, 183-187 (2003) https://doi.org/10.1016/S0939-6411(03)00068-7 - J.B. Bell, R.A. Davies and E.J. Thompson, Herpes simplex encephalitis. A study of seven patients and their immunological response prior to routine acyclovir treatment, J. Infect., 47, 161-163 (2003) https://doi.org/10.1016/S0163-4453(03)00011-2
- H. Takahashi, N. Hato, N. Honda, H. Kisaki, H. Wakisaka, S. Matsumoto and K. Gyo, Effects of acyclovir on facial nerve paralysis induced by herpes simplex virus type 1 in mice, Auris Nasus Larynx., 30, 1-5 (2003)
- T. Hasegawa, M. Kurokawa, T.A. Yukawa, M. Horii and K. Shiraki, Inhibitory action of acyclovir(ACV) and penciclovir(PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV, Anti. Res., 27, 271-279 (1995) https://doi.org/10.1016/0166-3542(95)00007-9